Consumer Health

In 2023, analgesics is set to see strong growth supported by rising prices in the context of generally high rates of inflation. After strong growth in 2020 due to stockpiling and decline in 2021, the category returned to growth in 2022 and has…

In 2023, there have been stock shortages for some analgesics in key distribution channels in Saudi Arabia, resulting from producers, suppliers, and/or distributors. As a result, end consumers have been switching to alternative products containing the…

Despite general economic instability and a rise in prices, the analgesics category in 2023 looks set to achieve a positive performance. However, the current value growth rate is likely to be slower than in the previous year. This can be attributed to…

Analgesics recorded a significant increase in retail volume terms in 2021 and this was followed by even more dynamic growth in 2022. The COVID-19 pandemic and the tough restrictions introduced in 2020 and the beginning of 2021 in order to prevent it…

Demand for both adult and paediatric analgesics continued to grow in retail volume terms in 2023. Such products are widely used in Poland, particularly in the case of pain which is fleeting or immediate. With the rapid pace of modern life, consumers…

Analgesics benefitted from the era of COVID-19, as consumers sought out pain relief such as acetaminophen and ibuprofen, both of which saw extensive coverage in the media as low-cost products that could treat symptoms of the virus quickly and…

Analgesics is expected to register moderate constant value growth in 2023. In spite of continuing very high inflation, volume growth is also expected to be healthy, and is supported by continuing population growth. Price limits on analgesics is also…

Per capita consumption of analgesics continued to increase in Norway during 2023 after 2022 saw significant increases in consumption of these products. While there was some stockpiling of analgesics seen in Norway during the early stages of the…

Analgesics continues to achieve strong value growth in North Macedonia in 2023 as a result of strong consumer demand for systemic analgesics, especially adult ibuprofen, adult acetaminophen and adult aspirin. Topical analgesics are outperforming…

Analgesics remains the largest category in consumer health in Nigeria. Sales continued to rise in 2023, supported by strong brand positioning and consumer awareness. Other factors driving growth included affordability, widespread availability and a…